Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 56 entries
Sorted by: Best Match Show Resources per page
Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature.

Current oncology reports

Collée GE, van der Wilk BJ, van Lanschot JJB, Busschbach JJ, Timmermans L, Lagarde SM, Kranenburg LW.
PMID: 32725550
Curr Oncol Rep. 2020 Jul 28;22(10):101. doi: 10.1007/s11912-020-00962-3.

PURPOSE OF REVIEW: Medical decisions concerning active surveillance are complex, especially when evidence on superiority of one of the treatments is lacking. Decision aids have been developed to facilitate shared decision-making on whether to pursue an active surveillance strategy....

Cite
Collée GE, van der Wilk BJ, van Lanschot JJB, et al. Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature. Curr Oncol Rep. 2020;22(10):101doi: 10.1007/s11912-020-00962-3.
Collée, G. E., van der Wilk, B. J., van Lanschot, J. J. B., Busschbach, J. J., Timmermans, L., Lagarde, S. M., & Kranenburg, L. W. (2020). Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature. Current oncology reports, 22(10), 101. https://doi.org/10.1007/s11912-020-00962-3
Collée, G E, et al. "Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature." Current oncology reports vol. 22,10 (2020): 101. doi: https://doi.org/10.1007/s11912-020-00962-3
Collée GE, van der Wilk BJ, van Lanschot JJB, Busschbach JJ, Timmermans L, Lagarde SM, Kranenburg LW. Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature. Curr Oncol Rep. 2020 Jul 28;22(10):101. doi: 10.1007/s11912-020-00962-3. PMID: 32725550; PMCID: PMC7387328.
Copy Download .nbib Format: NLM
Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic.

Hernia : the journal of hernias and abdominal wall surgery

Lima DL, Pereira X, Dos Santos DC, Camacho D, Malcher F.
PMID: 32548667
Hernia. 2020 Oct;24(5):1141-1142. doi: 10.1007/s10029-020-02250-2. Epub 2020 Jun 16.

No abstract available.

Cite
Lima DL, Pereira X, Dos Santos DC, et al. Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic. Hernia. 2020;24(5):1141-1142doi: 10.1007/s10029-020-02250-2.
Lima, D. L., Pereira, X., Dos Santos, D. C., Camacho, D., & Malcher, F. (2020). Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic. Hernia : the journal of hernias and abdominal wall surgery, 24(5), 1141-1142. https://doi.org/10.1007/s10029-020-02250-2
Lima, D L, et al. "Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic." Hernia : the journal of hernias and abdominal wall surgery vol. 24,5 (2020): 1141-1142. doi: https://doi.org/10.1007/s10029-020-02250-2
Lima DL, Pereira X, Dos Santos DC, Camacho D, Malcher F. Where are the hernias? A paradoxical decrease in emergency hernia surgery during COVID-19 pandemic. Hernia. 2020 Oct;24(5):1141-1142. doi: 10.1007/s10029-020-02250-2. Epub 2020 Jun 16. PMID: 32548667; PMCID: PMC7296514.
Copy Download .nbib Format: NLM
Active Surveillance of Renal Masses: The Role of Radiology.

Radiology

Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG.
PMID: 34812670
Radiology. 2022 Jan;302(1):11-24. doi: 10.1148/radiol.2021204227. Epub 2021 Nov 23.

Active surveillance of renal masses, which includes serial imaging with the possibility of delayed treatment, has emerged as a viable alternative to immediate therapeutic intervention in selected patients. Active surveillance is supported by evidence that many benign masses are...

Cite
Schieda N, Krishna S, Pedrosa I, et al. Active Surveillance of Renal Masses: The Role of Radiology. Radiology. 2021;302(1):11-24doi: 10.1148/radiol.2021204227.
Schieda, N., Krishna, S., Pedrosa, I., Kaffenberger, S. D., Davenport, M. S., & Silverman, S. G. (2022). Active Surveillance of Renal Masses: The Role of Radiology. Radiology, 302(1), 11-24. https://doi.org/10.1148/radiol.2021204227
Schieda, Nicola, et al. "Active Surveillance of Renal Masses: The Role of Radiology." Radiology vol. 302,1 (2022): 11-24. doi: https://doi.org/10.1148/radiol.2021204227
Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG. Active Surveillance of Renal Masses: The Role of Radiology. Radiology. 2022 Jan;302(1):11-24. doi: 10.1148/radiol.2021204227. Epub 2021 Nov 23. PMID: 34812670.
Copy Download .nbib Format: NLM
The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research.

Annals of surgical oncology

Herb J, Ollila DW, Hollis A, O'Shea K, Googe P, Stitzenberg K.
PMID: 34120267
Ann Surg Oncol. 2022 Jan;29(1):42-44. doi: 10.1245/s10434-021-10305-6. Epub 2021 Jun 12.

No abstract available.

Cite
Herb J, Ollila DW, Hollis A, et al. The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research. Ann Surg Oncol. 2021;29(1):42-44doi: 10.1245/s10434-021-10305-6.
Herb, J., Ollila, D. W., Hollis, A., O'Shea, K., Googe, P., & Stitzenberg, K. (2022). The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research. Annals of surgical oncology, 29(1), 42-44. https://doi.org/10.1245/s10434-021-10305-6
Herb, Joshua, et al. "The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research." Annals of surgical oncology vol. 29,1 (2022): 42-44. doi: https://doi.org/10.1245/s10434-021-10305-6
Herb J, Ollila DW, Hollis A, O'Shea K, Googe P, Stitzenberg K. The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research. Ann Surg Oncol. 2022 Jan;29(1):42-44. doi: 10.1245/s10434-021-10305-6. Epub 2021 Jun 12. PMID: 34120267.
Copy Download .nbib Format: NLM
Reply by Authors.

The Journal of urology

Carlsson S, Benfante N, Alvim R, Sjoberg DD, Vickers A, Reuter VE, Fine SW, Vargas HA, Wiseman M, Mamoor M, Ehdaie B, Laudone V, Scardino P, Eastham J, Touijer K.
PMID: 32698714
J Urol. 2020 Nov;204(5):1064-1065. doi: 10.1097/JU.0000000000001292. Epub 2020 Jul 23.

No abstract available.

Cite
Carlsson S, Benfante N, Alvim R, et al. Reply by Authors. J Urol. 2020;204(5):1064-1065doi: 10.1097/JU.0000000000001292.
Carlsson, S., Benfante, N., Alvim, R., Sjoberg, D. D., Vickers, A., Reuter, V. E., Fine, S. W., Vargas, H. A., Wiseman, M., Mamoor, M., Ehdaie, B., Laudone, V., Scardino, P., Eastham, J., & Touijer, K. (2020). Reply by Authors. The Journal of urology, 204(5), 1064-1065. https://doi.org/10.1097/JU.0000000000001292
Carlsson, S, et al. "Reply by Authors." The Journal of urology vol. 204,5 (2020): 1064-1065. doi: https://doi.org/10.1097/JU.0000000000001292
Carlsson S, Benfante N, Alvim R, Sjoberg DD, Vickers A, Reuter VE, Fine SW, Vargas HA, Wiseman M, Mamoor M, Ehdaie B, Laudone V, Scardino P, Eastham J, Touijer K. Reply by Authors. J Urol. 2020 Nov;204(5):1064-1065. doi: 10.1097/JU.0000000000001292. Epub 2020 Jul 23. PMID: 32698714.
Copy Download .nbib Format: NLM
Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017.

European urology

Froehner M, Koch R, Thomas C.
PMID: 32381458
Eur Urol. 2020 Aug;78(2):e91. doi: 10.1016/j.eururo.2020.03.010. Epub 2020 May 04.

No abstract available.

Cite
Froehner M, Koch R, Thomas C. Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017. Eur Urol. 2020;78(2):e91doi: 10.1016/j.eururo.2020.03.010.
Froehner, M., Koch, R., & Thomas, C. (2020). Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017. European urology, 78(2), e91. https://doi.org/10.1016/j.eururo.2020.03.010
Froehner, Michael, et al. "Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017." European urology vol. 78,2 (2020): e91. doi: https://doi.org/10.1016/j.eururo.2020.03.010
Froehner M, Koch R, Thomas C. Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017. Eur Urol. 2020 Aug;78(2):e91. doi: 10.1016/j.eururo.2020.03.010. Epub 2020 May 04. PMID: 32381458.
Copy Download .nbib Format: NLM
Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience.

European urology

Villers A, Olivier J.
PMID: 32389440
Eur Urol. 2020 Jul;78(1):112. doi: 10.1016/j.eururo.2020.04.003. Epub 2020 May 07.

No abstract available.

Cite
Villers A, Olivier J. Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience. Eur Urol. 2020;78(1):112doi: 10.1016/j.eururo.2020.04.003.
Villers, A., & Olivier, J. (2020). Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience. European urology, 78(1), 112. https://doi.org/10.1016/j.eururo.2020.04.003
Villers, Arnauld, and Olivier, Jonathan. "Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience." European urology vol. 78,1 (2020): 112. doi: https://doi.org/10.1016/j.eururo.2020.04.003
Villers A, Olivier J. Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience. Eur Urol. 2020 Jul;78(1):112. doi: 10.1016/j.eururo.2020.04.003. Epub 2020 May 07. PMID: 32389440.
Copy Download .nbib Format: NLM
Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques.

European urology

Ahmad AE, Finelli A.
PMID: 28162816
Eur Urol. 2017 Jun;71(6):872-873. doi: 10.1016/j.eururo.2017.01.035. Epub 2017 Feb 02.

No abstract available.

Cite
Ahmad AE, Finelli A. Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques. Eur Urol. 2017;71(6):872-873doi: 10.1016/j.eururo.2017.01.035.
Ahmad, A. E., & Finelli, A. (2017). Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques. European urology, 71(6), 872-873. https://doi.org/10.1016/j.eururo.2017.01.035
Ahmad, Ardalan E, and Finelli, Antonio. "Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques." European urology vol. 71,6 (2017): 872-873. doi: https://doi.org/10.1016/j.eururo.2017.01.035
Ahmad AE, Finelli A. Active Surveillance Discussion for Low-risk Prostate Cancer: Patients' Preferences and Counseling Techniques. Eur Urol. 2017 Jun;71(6):872-873. doi: 10.1016/j.eururo.2017.01.035. Epub 2017 Feb 02. PMID: 28162816.
Copy Download .nbib Format: NLM
[Active surveillance for low-risk prostate cancer].

La Revue du praticien

Ploussard G.
PMID: 23682474
Rev Prat. 2013 Apr;63(4):485-8.

During the last decades, incidence of prostate cancer has increased at the expense of cases at low-risk of progression. Meanwhile, the concept of active surveillance has gained widespread acceptance in order to decease the risk of overtreatment. Active surveillance...

Cite
Ploussard G. Surveillance active du cancer de la prostate a faible risque evolutif. [Active surveillance for low-risk prostate cancer]. Rev Prat. 2013;63(4):485-8
Ploussard, G. (2013). Surveillance active du cancer de la prostate a faible risque evolutif. [Active surveillance for low-risk prostate cancer]. La Revue du praticien, 63(4), 485-8.
Ploussard, Guillaume. "Surveillance active du cancer de la prostate a faible risque evolutif." [Active surveillance for low-risk prostate cancer]. La Revue du praticien vol. 63,4 (2013): 485-8.
Ploussard G. Surveillance active du cancer de la prostate a faible risque evolutif. [Active surveillance for low-risk prostate cancer]. Rev Prat. 2013 Apr;63(4):485-8. French. PMID: 23682474.
Copy Download .nbib Format: NLM
[Active surveillance for low-risk prostate cancer].

Der Urologe. Ausg. A

Herlemann A, Stief CG.
PMID: 26831055
Urologe A. 2016 Feb;55(2):269-81. doi: 10.1007/s00120-015-0025-x.

Autopsy studies have confirmed the high prevalence of latent prostate cancer; however, only a certain portion of patients require definite treatment. Active surveillance is one of the treatment options which, according to national and international guidelines, should be offered...

Cite
Herlemann A, Stief CG. Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom. [Active surveillance for low-risk prostate cancer]. Urologe A. 2016;55(2):269-81doi: 10.1007/s00120-015-0025-x.
Herlemann, A., & Stief, C. G. (2016). Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom. [Active surveillance for low-risk prostate cancer]. Der Urologe. Ausg. A, 55(2), 269-81. https://doi.org/10.1007/s00120-015-0025-x
Herlemann, Annika, and Stief, Christian G. "Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom." [Active surveillance for low-risk prostate cancer]. Der Urologe. Ausg. A vol. 55,2 (2016): 269-81. doi: https://doi.org/10.1007/s00120-015-0025-x
Herlemann A, Stief CG. Aktive Überwachung beim Niedrig-Risiko-Prostatakarzinom. [Active surveillance for low-risk prostate cancer]. Urologe A. 2016 Feb;55(2):269-81. doi: 10.1007/s00120-015-0025-x. German. PMID: 26831055.
Copy Download .nbib Format: NLM
Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.

Journal of the National Comprehensive Cancer Network : JNCCN

[No authors listed]
PMID: 21739727
J Natl Compr Canc Netw. 2011 May;9(5):xxxvii-xlii.

No abstract available.

Cite
Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer. J Natl Compr Canc Netw. 2011;9(5):xxxvii-xlii
(2011). Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 9(5), xxxvii-xlii.
"Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer." Journal of the National Comprehensive Cancer Network : JNCCN vol. 9,5 (2011): xxxvii-xlii.
Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer. J Natl Compr Canc Netw. 2011 May;9(5):xxxvii-xlii. PMID: 21739727.
Copy Download .nbib Format: NLM
[Treatment of actinic keratosis prevents progression].

Nederlands tijdschrift voor geneeskunde

Beljaards RC.
PMID: 23484514
Ned Tijdschr Geneeskd. 2013;157(11):A5648.

Actinic keratoses are epidermal changes resulting from chronic ultraviolet irradiation of the skin and are regarded as premalignancies. All actinic keratoses should be treated to prevent their progression to squamous cell carcinoma. There are several therapeutic modalities, which usually...

Cite
Beljaards RC. Behandeling van actinische keratosen voorkomt erger. [Treatment of actinic keratosis prevents progression]. Ned Tijdschr Geneeskd. 2013;157(11):A5648
Beljaards, R. C. (2013). Behandeling van actinische keratosen voorkomt erger. [Treatment of actinic keratosis prevents progression]. Nederlands tijdschrift voor geneeskunde, 157(11), A5648.
Beljaards, Rob C. "Behandeling van actinische keratosen voorkomt erger." [Treatment of actinic keratosis prevents progression]. Nederlands tijdschrift voor geneeskunde vol. 157,11 (2013): A5648.
Beljaards RC. Behandeling van actinische keratosen voorkomt erger. [Treatment of actinic keratosis prevents progression]. Ned Tijdschr Geneeskd. 2013;157(11):A5648. Dutch. PMID: 23484514.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 56 entries